Author:
Siddardha Shiliveri Sadhan,Raja Kolluru Karthik,Garikapati Amrutha,Dronamraju Sameera,Kumar Sunil
Abstract
Embolia cutis medicamentosa is a rare complication of intramuscular injury that leads to varying degrees of necrosis of the skin and subcutaneous tissue. In 1924, embolia cutis medicamentosa or Nicolau syndrome (NS) was first portrayed after an intragluteal injection of bismuth salts was given for the treatment of syphilis but it has now been documented with several drugs. (Murthy et al., 2007)1. According to one hypothesis, embolia cutis medicamentosa occurs when an intramuscular drug is accidentally injected into the arterial lumen or wall, leading to vessel thrombosis, subcutaneous tissue and muscle necrosis (Senel et al., 2010)2. Necrosis develops after hyperemia, skin discoloration usually associated with severe pain and wide inflammatory livedoid dermatitis and haemorrhagic patch at the injection site (Hamilton et al., 2008)3. Severe cases may take an immediate clinical course and anticipate to death.
Publisher
Akshantala Enterprises Private Limited
Reference5 articles.
1. Nicolau's syndrome following diclofenac administration: a report of two cases;Murthy;Indian J Dermatol Venereol Leprol,2007
2. A review of the literature;Şenel E. Nicolau syndrome;Clin Med Insights Dermatol,2010
3. [3] Hamilton B, Fowler P, Galloway H, et al. Nicolau syndrome in an athlete following intra-muscular diclofenac injection. Acta Orthop Belg 2008;74(6):860-4.
4. Nicolau syndrome following diclofenac administration;Ezzedine;Br J Dermatol,2004
5. Nicolau syndrome and perforator vessels: a new viewpoint for an old problem;Okan;Cutan Ocul Toxicol,2010
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献